P02 SS ATTACHMENT.docx

SOURCES SOUGHT

Sleep Studies Cleveland This is a Sources Sought (SS) Notice only; it is not a Solicitation (i.e., Request for Proposal, Request for Quotation, or Invitation for Bids). This SS is part of the Government’s market research effort to determine the scope of industry capabilities and interest and will be treated as information only. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responses to this SS are strictly voluntary, and the Government will not pay respondents for information provided in response to this SS. Responses to this SS will not be returned, and respondents will not be notified of the result of the review. Although responses to the questions posed by the Government would be most beneficial to this market research effort.

The purpose of this SS is to conduct Market Research to determine an acquisition strategy, to include determining if there are a sufficient number of Small Businesses capable of performing the requirements to warrant a set-aside, for the procurement of Sleep Studies at the Louis Stokes Cleveland VA Medical Center (CLE VAMC), 10701 East Blvd., Cleveland, OH 44106.

The WatchPAT is an FDA-cleared, non-invasive home sleep apnea testing device designed to assess sleep architecture and identify sleep-disordered breathing events. The system utilizes peripheral arterial tone (PAT) signal technology, along with oximetry, actigraphy, and heart rate variability, to accurately detect apneas, hypopneas, and related respiratory disturbances. Unlike traditional polysomnography, WatchPAT does not require complex wiring or in-lab monitoring; it measures physiological signals through a finger-mounted probe and chest sensor, allowing patients to complete studies in the comfort of their own home while maintaining clinical accuracy. Data is automatically uploaded to a secure cloud platform for interpretation by qualified sleep specialists. The WatchPAT provides validated measurements of key sleep indices including AHI, RDI, oxygen desaturation index, and sleep staging (REM, light, and deep sleep). The device has been independently validated against full polysomnography in multiple peer-reviewed studies and is widely used in VA and hospital settings to improve diagnostic accessibility and patient compliance for sleep apnea evaluation.

Potential sources must demonstrate the capability to provide the required equipment. Potential sources should submit:

• Point of Contact with email address and phone number;

• Business name and address;

• Applicable business socio-economic category;

• GSA, NAC, TAC, or SAC contract number if applicable;

• Capability statement and/or brochures of the equipment to allow for assessment of meeting the requirements stated above;

• SAM UEI number;

• Delivery days After Receipt of Order (ARO);

• What country the product is made in; and

• Whether or not your company is the OEM or a distributor. If a distributor, indicate who the OEM is and provide an authorized distributor letter.

Proprietary/Competition Sensitive information (appropriately marked) will be protected from disclosure to the greatest extent practical, however it is preferred that respondents do not provide proprietary or otherwise restricted responses unless they are indicating proprietary technical characteristics.

Vendors are hereby notified that if a competitive solicitation is issued on the Beta SAM website https://sam.gov at a later date, all interested parties must respond to that Solicitation announcement separately from any response to this SS announcement. This SS does not restrict the Government's acquisition approach on a future Solicitation.

No faxes, courier-delivered, or telephone inquiries/submissions will be accepted. Responses should be submitted to Rachelle J. Hamer, Contracting Officer, at rachelle.hamer@va.gov, by Thursday October 30, 2025, by 11AM ET. Enter “RFI 36C25026Q0068 | Sleep Studies CLE” in the email subject line.